This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Respiratory specialist nurse Maria Eurton discusses case examples to explain how to approach common diagnostic challenges in ...

Despite affecting thousands of Ugandans, asthma remains widely misunderstood. Dr Kanishka Salunkhe, a pulmonologist, breaks down the common myths that delay diagnosis, fuel fear, and ...

Tezspire (tezepelumab-ekko) is a monthly injection used to treat severe asthma. It was approved by the FDA in 2021 for use in addition to other asthma controlling medicines in people 12 and older.

Asthma care continues to develop, particularly in how treatment and long-term management are approached. This article outlines current treatment and management recommendations for patients aged 12 and ...

A new option for hard-to-control asthma: The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma. Designed to reduce flare-ups: The injectable ...

Scientists working in the School of Biochemistry and Immunology at the Trinity Biomedical Sciences Institute (TBSI) report they have uncovered a new strategy in mice for treating severe asthma. The ...

I also have a dry cough that’s been going on for about 13-14 years. I’m a healthy 62-year-old and read that it is called ...